Top Premarket Gainers
8:06AM ET 10/12/2022 MT NewswiresHempacco (HPCO) shares surged 63% premarket Wednesday after the company reported revenue of about $2.8 million for the six months ended June 30, a 486%...
Cel-Sci Reports Positive Data From Phase 3 Study Of Neoadjuvant Multikine In Locally Advanced Head, Neck Cancer
1:12PM ET 9/12/2022 MT NewswiresCel-Sci (CVM) reported Monday positive data from a phase 3 study of its Neoadjuvant Multikine injection in terms of tumor response and overall survival in...
Cel-Sci Says Positive Findings From Phase 3 Trial of Head, Neck Cancer Drug Now Published
10:54AM ET 8/19/2022 MT NewswiresCel-Sci (CVM) said Friday that positive findings from its phase 3 trial of Multikine in head and neck cancer have been published on clinicaltrials.gov per...
--EF Hutton Initiates Cel-Sci With Buy Rating, $17 Price Target
1:42PM ET 4/08/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
--EF Hutton Initiates Cel-Sci at Buy with $17 Price Target
11:02AM ET 4/07/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
-- Earnings Flash (CVM) CEL-SCI CORPORATION Posts Q1 Loss $-0.20
9:03AM ET 2/14/2022 MT Newswires...